Skip Nav Destination
Issues
Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations
Radhika A. Patel; Ilsa Coleman; Martine P. Roudier; Eric Q. Konnick; Brian Hanratty; Ruth Dumpit; Jared M. Lucas; Lisa S. Ang; Jin-Yih Low; Maria S. Tretiakova; Gavin Ha; John K. Lee; Lawrence D. True; Angelo M. De Marzo; Peter S. Nelson; Colm Morrissey; Colin C. Pritchard; Michael C. Haffner
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer
Margaret L. Axelrod; Yu Wang; Yaomin Xu; Xiaopeng Sun; Cosmin A. Bejan; Paula I. Gonzalez-Ericsson; Sara Nunnery; Riley E. Bergman; Joshua Donaldson; Angel L. Guerrero-Zotano; Chiara Massa; Barbara Seliger; Melinda Sanders; Ingrid A. Mayer; Justin M. Balko
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer
Stefano Marastoni; Ainhoa Madariaga; Aleksandra Pesic; Sree Narayanan Nair; Zhu Juan Li; Zvi Shalev; Troy Ketela; Ilaria Colombo; Victoria Mandilaras; Michael Cabanero; Jeff P. Bruce; Xuan Li; Swati Garg; Lisa Wang; Eric X. Chen; Sarbjot Gill; Neesha C. Dhani; Wenjiang Zhang; Melania Pintilie; Valerie Bowering; Marianne Koritzinsky; Robert Rottapel; Bradly G. Wouters; Amit M. Oza; Anthony M. Joshua; Stephanie Lheureux
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
Paul A. Hamlin; Vasile Musteata; Steven I. Park; Christine Burnett; Kristina Dabovic; Thomas Strack; Eric T. Williams; Banmeet S. Anand; Jack P. Higgins; Daniel O. Persky
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
Anne W.J. Martens; Joanne M. Rietveld; Renate de Boer; Fleur S. Peters; An Ngo; Lotte W.H.G. van Mil; Koen de Heer; Marcel Spaargaren; Christie P.M. Verkleij; Niels W.C.J. van de Donk; Homer C. Adams, III; Eric Eldering; Carel J.M. van Noesel; Raluca Verona; Arnon P. Kater
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
Husain Yar Khan; Misako Nagasaka; Yiwei Li; Amro Aboukameel; Md. Hafiz Uddin; Rachel Sexton; Sahar Bannoura; Yousef Mzannar; Mohammed Najeeb Al-Hallak; Steve Kim; Rafic Beydoun; Yosef Landesman; Hirva Mamdani; Dipesh Uprety; Philip A. Philip; Ramzi M. Mohammad; Anthony F. Shields; Asfar S. Azmi
Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia
Glenn J. Hanna; Alessandro Villa; Nikhil Mistry; Yonghui Jia; Charles T. Quinn; Madison M. Turner; Kristen D. Felt; Kathleen Pfaff; Robert I. Haddad; Ravindra Uppaluri; Scott J. Rodig; Sook-Bin Woo; Ann Marie Egloff; F. Stephen Hodi
Advertisement
